Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap239.64M
Enterprise Value113.22M
P/E Ratio-3.54
PEG Ratio0.05
Price/Sales Ratio0.15
Price/Book Ratio0.22
Enterprise/Revenue0.02
Enterprise/EBITDA0.36

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.04
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.05

Income Statement

Revenue972.01M
Revenue/Share0.58
Gross Profit287.22M
EBITDA48.1M
Net Income-40.74M
Diluted EPS-0.02

Balance Sheet

Total Cash209.45M
Total Cash/Share0.12
Total Debt73.02M
Total Debt/Equity0.11
Current Ratio2.01
Book Value Per Share0.42

Price History

52-Week Change-45
52-Week High0.19
52-Week Low0.09
Moving Average 50 Days0.12
Moving Average 200 Days0.14

Statistics

Average Volume289,830
Shares Outstanding1.68B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-6.12
Last Split FactorN/A
Last Split DateN/A
AD